- $512.77m
- -$786.12m
- CNY126.34m
- 81
- 19
- 81
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,840 | 3,688 | 1,654 | 577 | 126 |
Cost of Revenue | |||||
Gross Profit | 8,474 | 3,043 | 1,576 | 251 | -33.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,991 | 2,822 | 731 | 907 | 457 |
Operating Profit | 3,849 | 866 | 923 | -330 | -331 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,891 | 1,221 | 846 | -270 | 101 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,264 | 959 | 586 | -362 | 39.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3,264 | 959 | 589 | -362 | 39.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3,264 | 959 | 589 | -362 | 39.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 10.9 | 3.5 | 2.62 | -0.761 | 0.195 |